283 related articles for article (PubMed ID: 19669651)
21. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.
Bäumer D; Hilton D; Paine SM; Turner MR; Lowe J; Talbot K; Ansorge O
Neurology; 2010 Aug; 75(7):611-8. PubMed ID: 20668261
[TBL] [Abstract][Full Text] [Related]
22. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.
Mackenzie IR; Ansorge O; Strong M; Bilbao J; Zinman L; Ang LC; Baker M; Stewart H; Eisen A; Rademakers R; Neumann M
Acta Neuropathol; 2011 Jul; 122(1):87-98. PubMed ID: 21604077
[TBL] [Abstract][Full Text] [Related]
23. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
[TBL] [Abstract][Full Text] [Related]
24. A new subtype of frontotemporal lobar degeneration with FUS pathology.
Neumann M; Rademakers R; Roeber S; Baker M; Kretzschmar HA; Mackenzie IR
Brain; 2009 Nov; 132(Pt 11):2922-31. PubMed ID: 19674978
[TBL] [Abstract][Full Text] [Related]
25. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
26. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study.
Yokota O; Tsuchiya K; Terada S; Ishizu H; Uchikado H; Ikeda M; Oyanagi K; Nakano I; Murayama S; Kuroda S; Akiyama H
Acta Neuropathol; 2008 May; 115(5):561-75. PubMed ID: 18080129
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis.
Kobayashi Z; Tsuchiya K; Arai T; Aoki M; Hasegawa M; Ishizu H; Akiyama H; Mizusawa H
J Neurol Sci; 2010 Jun; 293(1-2):6-11. PubMed ID: 20409561
[TBL] [Abstract][Full Text] [Related]
28. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease.
Woulfe J; Gray DA; Mackenzie IR
Brain Pathol; 2010 May; 20(3):589-97. PubMed ID: 19832837
[TBL] [Abstract][Full Text] [Related]
29. Transportin1: a marker of FTLD-FUS.
Brelstaff J; Lashley T; Holton JL; Lees AJ; Rossor MN; Bandopadhyay R; Revesz T
Acta Neuropathol; 2011 Nov; 122(5):591-600. PubMed ID: 21847626
[TBL] [Abstract][Full Text] [Related]
30. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
[TBL] [Abstract][Full Text] [Related]
31. Gigaxonin mutation analysis in patients with NIFID.
Dequen F; Cairns NJ; Bigio EH; Julien JP
Neurobiol Aging; 2011 Aug; 32(8):1528-9. PubMed ID: 19782434
[TBL] [Abstract][Full Text] [Related]
32. Mutated FUS in familial amyotrophic lateral sclerosis involves multiple hnRNPs in the formation of neuronal cytoplasmic inclusions.
Honda H; Yoshimura M; Arahata H; Yagita K; Sadashima S; Hamasaki H; Shijo M; Koyama S; Noguchi H; Sasagasako N
J Neuropathol Exp Neurol; 2023 Feb; 82(3):231-241. PubMed ID: 36592411
[TBL] [Abstract][Full Text] [Related]
33. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
[TBL] [Abstract][Full Text] [Related]
34. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
Cairns NJ; Grossman M; Arnold SE; Burn DJ; Jaros E; Perry RH; Duyckaerts C; Stankoff B; Pillon B; Skullerud K; Cruz-Sanchez FF; Bigio EH; Mackenzie IR; Gearing M; Juncos JL; Glass JD; Yokoo H; Nakazato Y; Mosaheb S; Thorpe JR; Uryu K; Lee VM; Trojanowski JQ
Neurology; 2004 Oct; 63(8):1376-84. PubMed ID: 15505152
[TBL] [Abstract][Full Text] [Related]
35. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
[TBL] [Abstract][Full Text] [Related]
36. Topography of hemispheric white matter pathology in ten cases of neuronal intermediate filament inclusion disease.
Armstrong RA
Clin Neuropathol; 2018; 37(5):239-244. PubMed ID: 29956645
[TBL] [Abstract][Full Text] [Related]
37. Topography of FUS pathology distinguishes late-onset BIBD from aFTLD-U.
Lee EB; Russ J; Jung H; Elman LB; Chahine LM; Kremens D; Miller BL; Branch Coslett H; Trojanowski JQ; Van Deerlin VM; McCluskey LF
Acta Neuropathol Commun; 2013 May; 1(9):1-11. PubMed ID: 24027631
[TBL] [Abstract][Full Text] [Related]
38. Characteristic Features of FUS Inclusions in Spinal Motor Neurons of Sporadic Amyotrophic Lateral Sclerosis.
Ikenaka K; Ishigaki S; Iguchi Y; Kawai K; Fujioka Y; Yokoi S; Abdelhamid RF; Nagano S; Mochizuki H; Katsuno M; Sobue G
J Neuropathol Exp Neurol; 2020 Apr; 79(4):370-377. PubMed ID: 32142134
[TBL] [Abstract][Full Text] [Related]
39. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis.
Oketa Y; Higashida K; Fukasawa H; Tsukie T; Ono S
Acta Neurol Scand; 2013 Oct; 128(4):257-64. PubMed ID: 23448665
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
